Our People » Andreas Grabrucker



Office: AD3-018,
Analog Devices Building,
University of Limerick.

+353 61 237756

andreas.grabrucker@ul.ie

Qualifications

M.Sc. in Biology and Ph.D. in molecular medicine

Research and Teaching Interests

The investigation of genetic and non-genetic factors contributing to neuronal dysfunction & the development of novel research and treatment strategies using nanotechnology in the area of translational neuroscience.

Andreas Grabrucker

Dr Grabrucker received his MSc in Biology with a focus on genetics in 2005 from the Technical University of Munich, Germany. From 2005 to 2009 he investigated the molecular mechanisms of synaptic plasticity in his doctoral at Ulm University, Germany. After receiving his Ph.D., he continued his neuroscientific research in the United States at Stanford University’s Department of Psychiatry and Behavioral Sciences until 2011.  In 2011, he returned to University of Ulm as Assistant Professor, where he headed the research group “Molecular analysis of synaptopathies”. At the same time he took up the position of Executive Director of the Neurocenter of the University of Ulm. Since 2017, he is a lecturer at the Department of Biological Sciences, at the University of Limerick.

Research projects

Understanding disease, Invitro models for brain diseases

Targeted therapy, Characterisation of Nanoparticles

New technologies for detection, Proteome analysis of disease models

 

 

Additional Links


1. Tosi G, Vilella A, Schmeisser MJ, Boeckers TM, Ruozi B, Vandelli MA, Forni F, Zoli M, Grabrucker AM: Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport. Journal of Controlled Release 2014; 177C: 96-107.
DOI: 10.1016/j.jconrel.2014.01.004
• View Journal Article


2. Grabrucker S, Jannetti L, Eckert M, Gaub S, Chhabra R, Pfaender S, Mangus K, Reddy PP, Rankovic V, Schmeisser MJ, Kreutz MR, Ehret G, Boeckers TM, Grabrucker AM: Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders. Brain 2014; 137 (Pt 1): 137-152.
DOI: 10.1093/brain/awt303
• View Journal Article